Literature DB >> 11119590

Mutations that affect dimer formation and helicase activity of the hepatitis C virus helicase.

Y L Khu1, E Koh, S P Lim, Y H Tan, S Brenner, S G Lim, W J Hong, P Y Goh.   

Abstract

Interaction between viral proteins is necessary for viral replication and viral particle assembly. We used the yeast two-hybrid assay to identify interactions among all the mature proteins of the hepatitis C virus. The interaction between NS3 and NS3 was one of the strongest viral protein-protein interactions detected. The minimal region required for this interaction was mapped to a specific subdomain of 174 amino acids in the N terminus of the helicase region. Random mutations in the minimal region were generated by PCR, and mutants that failed to interact with a wild-type minimal fragment were isolated using the yeast two-hybrid assay as a screen. Three of these mutations resulted in a reduction or a loss of interaction between helicases. Analytical gel filtration showed that in the presence of an oligonucleotide, wild-type helicases form dimers whereas the mutants remain mostly monomeric. All three mutants were partially or almost inactive when assayed for helicase activity in vitro. Mixing a mutant helicase (Y267S) with wild-type helicase did not dramatically affect helicase activity. These data indicate that dimerization of the helicase is important for helicase activity. The mutations that reduce self-association of the helicase may define the key residues involved in NS3-NS3 dimerization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11119590      PMCID: PMC113914          DOI: 10.1128/JVI.75.1.205-214.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  The helicase from hepatitis C virus is active as an oligomer.

Authors:  M K Levin; S S Patel
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

2.  Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A.

Authors:  P Gallinari; C Paolini; D Brennan; C Nardi; C Steinkühler; R De Francesco
Journal:  Biochemistry       Date:  1999-04-27       Impact factor: 3.162

3.  Escherichia coli DNA helicase II is active as a monomer.

Authors:  L E Mechanic; M C Hall; S W Matson
Journal:  J Biol Chem       Date:  1999-04-30       Impact factor: 5.157

4.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

5.  Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1.

Authors:  J H Xiao; I Davidson; H Matthes; J M Garnier; P Chambon
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

6.  An oligomeric form of E. coli UvrD is required for optimal helicase activity.

Authors:  J A Ali; N K Maluf; T M Lohman
Journal:  J Mol Biol       Date:  1999-11-05       Impact factor: 5.469

7.  Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding.

Authors:  J L Kim; K A Morgenstern; J P Griffith; M D Dwyer; J A Thomson; M A Murcko; C Lin; P R Caron
Journal:  Structure       Date:  1998-01-15       Impact factor: 5.006

8.  Structure-based mutagenesis study of hepatitis C virus NS3 helicase.

Authors:  C Lin; J L Kim
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

9.  Complex formation of NS5B with NS3 and NS4A proteins of hepatitis C virus.

Authors:  S Ishido; T Fujita; H Hotta
Journal:  Biochem Biophys Res Commun       Date:  1998-03-06       Impact factor: 3.575

10.  Product release is the major contributor to kcat for the hepatitis C virus helicase-catalyzed strand separation of short duplex DNA.

Authors:  D J Porter; S A Short; M H Hanlon; F Preugschat; J E Wilson; D H Willard; T G Consler
Journal:  J Biol Chem       Date:  1998-07-24       Impact factor: 5.157

View more
  17 in total

1.  Conserved region CR2 of Epstein-Barr virus nuclear antigen leader protein is a multifunctional domain that mediates self-association as well as nuclear localization and nuclear matrix association.

Authors:  Michiko Tanaka; Akihiko Yokoyama; Mie Igarashi; Go Matsuda; Kentaro Kato; Mikiko Kanamori; Kanji Hirai; Yasushi Kawaguchi; Yuji Yamanashi
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  The nonstructural protein 3 protease/helicase requires an intact protease domain to unwind duplex RNA efficiently.

Authors:  David N Frick; Ryan S Rypma; Angela M I Lam; Baohua Gu
Journal:  J Biol Chem       Date:  2003-10-29       Impact factor: 5.157

3.  The active form of Xp54 RNA helicase in translational repression is an RNA-mediated oligomer.

Authors:  Nicola Minshall; Nancy Standart
Journal:  Nucleic Acids Res       Date:  2004-02-24       Impact factor: 16.971

Review 4.  Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target.

Authors:  Kevin D Raney; Suresh D Sharma; Ibrahim M Moustafa; Craig E Cameron
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

Review 5.  Understanding helicases as a means of virus control.

Authors:  D N Frick; A M I Lam
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

6.  Hepatitis C virus NS3 helicase forms oligomeric structures that exhibit optimal DNA unwinding activity in vitro.

Authors:  Bartek Sikora; Yingfeng Chen; Cheryl F Lichti; Melody K Harrison; Thomas A Jennings; Yong Tang; Alan J Tackett; John B Jordan; Joshua Sakon; Craig E Cameron; Kevin D Raney
Journal:  J Biol Chem       Date:  2008-02-18       Impact factor: 5.157

7.  Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus.

Authors:  Byounghoon Hwang; Jung Sun Cho; Hyeon Ju Yeo; Jung-Hye Kim; Kyung Min Chung; Kyungsook Han; Sung Key Jang; Seong-Wook Lee
Journal:  RNA       Date:  2004-07-09       Impact factor: 4.942

8.  NS3 helicase from the hepatitis C virus can function as a monomer or oligomer depending on enzyme and substrate concentrations.

Authors:  Thomas A Jennings; Samuel G Mackintosh; Melody K Harrison; Deniz Sikora; Bartek Sikora; Bhuvanesh Dave; Alan J Tackett; Craig E Cameron; Kevin D Raney
Journal:  J Biol Chem       Date:  2008-12-16       Impact factor: 5.157

9.  Subgenomic HCV RNA replication and its localization in the nucleus of the infected cells.

Authors:  Zaki Monawar Eisa
Journal:  Saudi J Biol Sci       Date:  2011-02-03       Impact factor: 4.219

10.  Protein-protein interactions between hepatitis C virus nonstructural proteins.

Authors:  Maria Dimitrova; Isabelle Imbert; Marie Paule Kieny; Catherine Schuster
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.